Effectiveness of over-the-counter nicotine replacement therapy: A qualitative review of nonrandomized trials

Nicotine and Tobacco Research

Volumn 13, Issue 7, 2011, Pages 512-522

  Hughes, John R ^a,b   Peters, Erica N ^c   Naud, Shelly ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; NON PRESCRIPTION DRUG;

CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; DRUG EFFICACY; HUMAN; NICOTINE REPLACEMENT THERAPY; PATIENT COMPLIANCE; PATIENT COUNSELING; PRIORITY JOURNAL; QUALITATIVE RESEARCH; RETROSPECTIVE STUDY; REVIEW; SMOKING CESSATION; SYSTEMATIC REVIEW;

EID: 79960175346     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntr055     Document Type: Review

References (43)

1. Alberg, A., Margalit, R., Burke, A., Rasch, K., Stewart, N., Kline, J., et al. (2004). The influence of offering free transdermal nicotine patches on quit rates in a local health department's smoking cessation program. Addictive Behaviors, 29, 1763-1778. doi:10.1016/j.addbeh.2004.04.007.
2. Amori, G., & Lenox, R. H. (1989). Do volunteer subjects bias clinical trials? Journal of Clinical Psychopharmacology, 9, 321-327.
3. Bansal, M. A., Cummings, K. M., Hyland, A., & Giovino, G. A. (2004). Stop-smoking medications: Who uses them, who misuses them, and who is misinformed about them? Nicotine & Tobacco Research, 6, S303-S310.
4. Berg, C., An, L., Kirch, M., Guo, H., Thomas, J., Patten, C., et al. (2010). Failure to report attempts to quit smoking. Addictive Behaviors, 35, 900-904. doi:10.1016/j.addbeh.2010.06.009.
5. Bush, T., McAfee, T., Deprey, M., Mahoney, L., Fellows, J., McClure, J., et al. (2008). The impact of a free nicotine patch starter kit on quit rates in a state quit line. Nicotine & Tobacco Research, 10, 1516. doi:10.1080/14622200802323167.
6. Campbell, D. T., & Stanley, J. C. (1966). Experimental and quasi-experimental designs for research. Chicago, IL: Rand McNally College Publishing Company.
7. Cokkinides, V. E., Ward, E., Jemel, A., & Thun, M. J. (2005). Under-use of smoking-cessation treatments: Results from the National Health Interview Survey, 2000. American Journal of Preventive Medicine, 28, 119-122. doi:10.1016/j.amepre.2004.09.007.
8. Cummings, K., Hyland, A., Fix, B., Bauer, U., Celestino, P., Carling-Menter, S., et al. (2006). Free nicotine patch giveaway program: 12-month follow-up of participants. American Journal of Preventive Medicine, 31, 181-184. doi:10.1016/j.amepre.2006.03.027.
9. Cummings, K. M., Hyland, A., Ockene, J. K., Hymowitz, N., & Manley, M. (1997). Use of the nicotine skin patch by smokers in 20 communities in the nited States, 1992-1993. Tobacco Control, 6, S63-S70.
10. Fiore, M. C., Bailey, W. C., Cohen, S. J., Dorfman, S. F., Goldstein, M. G., Gritz, E. R., et al. (2000). Treating tobacco use and dependence. Clinical practice guideline. Rockville, MD: U.S. Public Health Service.
11. Gartlehner, G., Hansen, R., Nissman, D., Lohr, K., & Carey, T. (2006). A simple and valid tool distinguished efficacy from effectiveness studies. Journal of Clinical Epidemiology, 59, 1040-1048. doi:10.1016/j.jclinepi.2006.01.011.
12. Gilpin, E., Messer, K., & Pierce, J. (2006). Population effectiveness of pharmaceutical aids for smoking cessation: What is associated with increased success? Nicotine & Tobacco Research, 8, 661-669. doi:10.1080/14622200600910801.
13. Gilpin, E., & Pierce, J. P. (1994). Measuring smoking cessation: Problems with recall in the 1990 California Tobacco Survey. Cancer Epidemiology, Biomarkers & Prevention, 3, 613-617.
14. Gomez-Zamudio, M., Renaud, L., Labrie, L., Masse, R., Pineau, G., & Gagnon, L. (2004). Role of pharmacological aids and social supports in smoking cessation associated with Quebec's 2000 Quit and Win campaign. Preventive Medicine, 38, 662-667. doi:10.1016/j.vpmed.2003.12.015.
15. Hammond, D., Reid, J., Driezen, P., Cummings, K., Borland, R., Fong, G., et al. (2008). Smokers' use of nicotine replacement therapy for reasons other than stopping smoking: Findings from the ITC Four Country Survey. Addiction, 103, 1696-1703. doi:10.1111k/1360-0043.2008.02320.x.
16. Hawk, L., Jr., Higbee, C., Hyland, A., Alford, T., O'Connor, R., & Cummings, K. (2006). Concurrent quit & win and nicotine replacement therapy voucher giveaway programs: Participant characteristics and predictors of smoking abstinence. Journal of Public Health Management Practice, 12, 52-59.
17. Higgins, J. P. T., & Thompson, S. (2002). Quantifying heterogeneity in a meta-analysis. Statistics in Medicine, 21, 1539-1558. doi:10.1002/sim.1186.
18. Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003). Measuring inconsistency in meta-analysis. British Medical Journal, 327, 557-560. doi:10.1136.bmj.327.7414.557.
19. Hughes, J. R. (2001). The effectiveness of over-the-counter nicotine replacement: A rebuttal. Drug and Alcohol Review, 20, 319-324. doi:10.1080/09595230120079639.
20. Hughes, J. R. (2008). Significance of off-label use of NRT. Addiction, 103, 1704-1705. doi:10.1111/j.1360-0443.2008.02357.x.
21. Hughes, J. R. (2009). How confident should we be that smoking cessation treatments work? Addiction, 104, 1637-1640. doi:10.1111/j.1360-0443.2009.-2645.x.
22. Hughes, J. R., & Callas, P. (2010). Data to assess the generalizability of samples from studies of adult smokers. Nicotine & Tobacco Research, 12, 73-76. doi:10.1093/ntr.ntp16.
23. Hughes, J. R., Shiffman, S., Callas, P., & Zhang, J. (2003). A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tobacco Control, 12, 21-27. doi:10.1136.5c.12.1.21.
24. Hyland, A., Rezaishiraz, H., Giovino, G., Bauer, J. E., & Cummings, K. M. (2005). Over-the-counter availability of nicotine replacement therapy and smoking cessation. Nicotine & Tobacco Research, 7, 547-555. doi:10.1080/14622200500185975.
25. Klesges, R., Klesges, L., Vander Weg, M., DeBon, M., Poston, W., Ebbert, J., et al. (2007). Characteristics of Air Force personnel who choose pharmacological aids for smoking cessation following an involuntary tobacco ban and tobacco control program. Health Psychology, 26, 588-597. doi:10.1037/0278-6133.26.5.588.
26. Leischow, S., Ranger-Moore, J., Muramoto, M., & Matthews, E. (2004). Effectiveness of the nicotine inhaler for smoking cessation in an OTC setting. American Journal of Health Behavior, 28, 291-301.
27. Miller, N., Frieden, T. R., Liu, S. Y., Matte, T. D., Mostashari, F., Deitcher, D. R., et al. (2005). Effectiveness of a large-scale distribution programme of free nicotine patches: A prospective evaluation. Lancet, 365, 1849-1854. doi:10.1016/S0140-6736(05)66615-9.
28. Nash, J., McCrory, D., Nicholson, R., & Andrasik, F. (2005). Efficacy and effectiveness approaches in behavioral treatment trials. Headache, 45, 507-512.
29. Pierce, J. P., & Gilpin, E. A. (2002). Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. Journal of the American Medical Association, 288, 1260-1264. doi:10.1001/jama.288.10.1260.
30. Prochaska, J., Evers, K., Prochaska, J., Van Marter, D., & Johnson, J. (2007). Efficacy and effectiveness trial: Examples from smoking cessation and bullying prevention. Journal of Health Psychology, 12, 170-178. doi:10.1177/1359105307071751.
31. Shiffman, S., Brockwell, S., Pillitteri, J., & Gitchell, J. (2008a). Individual differences in adoption of treatment for smoking cessation: Demographic and smoking history characteristics. Drug and Alcohol Dependence, 93, 121-131. doi:10.1016/j.drugalcdep. 2007.09.005.
32. Shiffman, S., Brockwell, S. E., Pillitteri, J. L., & Gitchell, J. G. (2008b). Use of smoking-cessation treatments in the United States. American Journal of Preventive Medicine, 34, 102-111. doi:10.1016/j.amepre.2007.09.033.
33. Shiffman, S., Di Marino, M. E., & Sweeney, C. T. (2005). Characteristics of selectors of nicotine replacement therapy. Tobacco Control, 14, 346-355. doi:10.1136/5c.2004.009183.
34. Shiffman, S., & Sweeney, C. T. (2007). Ten years after the Rx-to OTC switch of nicotine replacement therapy: What have we learned about the benefits and risks of non-prescription availability? Health Policy, 86, 17-26. doi:10.1016/j.healthpol.2007.08.006.
35. Slavin, R. E. (1995). Best evidence synthesis: An intelligent alternative to meta-analysis. Journal of Clinical Epidemiology, 48, 9-18. doi:10.1016/0895-356(94)00097-A.
36. Solberg, L. I., Boyle, R. G., Davidson, G., Magnan, S., Carlsson, C. L., & Alesci, N. L. (2001). Aids to quitting tobacco use: How important are they outside controlled trials? Preventive Medicine, 33, 53-58. doi:10.1006/pmed.2001.0853.
37. Swartz, S., Cowan, T., Klayman, J., Welton, M., & Leonard, B. (2005). Use and effectiveness of tobacco telephone counseling and nicotine therapy in Maine. American Journal of Preventive Medicine, 29, 288-294. doi:10.1016/j.amepre.2005.06.015.
38. Thorndike, A. N., Biener, L., & Rigotti, N. A. (2002). Effect on smoking cessation of switching nicotine replacement therapy to over-the-counter status. American Journal of Public Health, 92, 437-442.
39. Tinkelman, D., Wilson, S., Willett, J., & Sweeney, C. (2007). Offering free NRT through a tobacco quitline: Impact on utilisation and quit rates. Tobacco Control, 16, i42-i46. doi:10.1136/5c.2007.019919.
40. Velicer, W., Fava, J., Keller, S., Ramelson, H., Friedman, R., Gulliver, S., et al. (2006). Evaluating nicotine replacement therapy and stage-based therapies in a population-based effectiveness trial. Journal of Consulting and Clinical Psychology, 74, 1162-1172. doi:10.1037/0022=006X.74.6.1162.
41. Walsh, R. (2008). Over-the-counter nicotine replacement therapy: A methodological review of the evidence supporting its effectiveness. Drug and alcohol Review, 27, 529-547. doi:10.1080/09595230802245527.
42. Warner, K. E., & Burns, D. M. (2003). Hardening and the hard-core smoker: Concepts, evidence, and implications. Nicotine & Tobacco Research, 5, 7-48. doi:10.1080/1462220021000060428.
43. West, R., & Zhou, X. (2007). Is nicotine replacement therapy for smoking cessation effective in the "real world" ? Findings from a prospective multinational cohort study. Thorax, 62, 998-1002. doi:10.1136/thx.2007.078758.